IMCD N.V., a global leading distribution partner, formulator of speciality chemicals and ingredients, and solutions provider, today announces its first nine months 2023 results. In the first 9 months, IMCD posted a gross profit of € 856 million (+EUR 3 million on a constant currency basis). Operating EBITA decline of 10% to €R 400 million (-6% on a constant currency basis) and net result decline of 19% to € 214 million (-16% on a constant currency basis). Free cash flow increase by 46% to € 364 million (first nine months of 2022: € 249 million).

Since the end of Q2 2023, IMCD successfully completed acquisitions in South Africa, UK, Puerto Rico, Chile, South Korea and Singapore/Vietnam

Piet van der Slikke, CEO: "Despite the prevailing difficult global economic conditions, and the lower demand in particular in the industrial market segment, IMCD delivered solid results. Gross profit was EUR 856 million which, on a constant currency basis, is in line with the first nine months of last year. Operating EBITA amounted to EUR 400 million (-6% forex adjusted). We generated a healthy cash flow of over EUR 364 million (+46%) together with a strong cash conversion margin of 89%. These results show, despite tough market circumstances, IMCD's resistant business model and we are confident that we will resume our growth path under improving conditions."